恩西芬:一种用于维持慢性阻塞性肺病的新选择
Emily M Hitt1, Alexa J Powell1
1Department of Pharmacotherapy, Washington State University College of Pharmacy and Pharmaceutical Sciences, Spokane, WA, USA.
概括
恩西芬是慢性阻塞性肺病 (COPD) 的新疗法,可以改善肺功能并减少症状. 它为COPD患者提供了一个潜在的新选择,尽管目前的治疗方法仍然存在症状.
科学领域:
- 肺部医学 肺部医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性阻塞性肺病 (COPD) 是致病率和死亡率的主要原因之一.
- 目前用于COPD的治疗方法旨在控制症状并预防恶化,但许多患者继续经历严重的症状负担.
研究的目的:
- 审查恩西芬的临床概况.
- 总结了支持恩西芬的批准的临床试验结果.
- 评估恩西芬对COPD患者护理和治疗决策的潜在影响.
主要方法:
- 在PubMed的文献搜索 (2024年10月至12月) 使用术语:恩西芬林,罗夫卢米拉斯特,奥图瓦耶尔TM,COPD.
- 包括二期和三期随机对照试验中使用恩西芬来治疗COPD.
- 不包括会议摘要,系统审查和元分析.
主要成果:
- 恩西芬在第三阶段ENHANCE试验中显著改善了肺功能.
- 临床研究表明,使用恩西芬治疗的患者的症状有所减轻.
- 恩西芬在研究的COPD患者群体中表现出可容忍的安全性.
结论:
- 恩西芬的批准代表了COPD管理的进步.
- 恩西芬可以作为一种有价值的补充疗法,用于COPD患者有持续症状.
- 这种新药可以增强COPD管理的治疗策略.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
324
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
324
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
Inhaled Medications
407
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
407
Chronic Obstructive Pulmonary Disease-V: Nursing Management
4.3K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
4.3K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
399
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
399
Acute Respiratory Failure-V
214
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
214


